Ipratropium

From Wikipedia, the free encyclopedia

Ipratropium
Systematic (IUPAC) name
[8-methyl-8-(1-methylethyl)- 8-azoniabicyclo[3.2.1] oct-3-yl] 3-hydroxy-2-phenyl-propanoate
Identifiers
CAS number 60205-81-4
ATC code R01AX03 R03BB01
PubChem 43232
DrugBank APRD00537
Chemical data
Formula C20H30NO3 
Mol. mass 332.457 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Protein binding 0 to 9% in vitro
Metabolism Hepatic
Half life 2 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

B(US)

Legal status

POM(UK)

Routes Inhalation

Ipratropium (as ipratropium bromide, trade name Atrovent) is an anticholinergic drug administered by inhalation for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a non-selective muscarinic antagonist, and does not diffuse into the blood, which prevents systemic side effects. Ipratropium is a derivative of atropine[1] but is a quaternary amine and therefore does not cross the blood-brain barrier, which prevents central side effects (anticholinergic syndrome).

Ipratropium is also combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the management of Chronic obstructive pulmonary disease (COPD) and asthma. Ipratropium is also combined with fenoterol (trade names Duovent and Berodual N) for the management of asthma.

If Ipratropium is inhaled, side effects resembling other anticholinergics are minimal. However, dry mouth and sedation have been reported.

[edit] Sources

[edit] Footnotes

  1. ^ Yamatake Y, Sasagawa S, Yanaura S, Okamiya Y (1977). "[Antiallergic asthma effect of ipratropium bromide (Sch 1000) in dogs (author's transl)]" (in Japanese). Nippon Yakurigaku Zasshi 73 (7): 785-91. PMID 145994.